These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27524984)

  • 1. Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections.
    Cheng WK; Plumb AW; Lai JC; Abraham N; Dutz JP
    Front Immunol; 2016; 7():284. PubMed ID: 27524984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells.
    Vogel AJ; Brown DM
    Front Immunol; 2015; 6():327. PubMed ID: 26161083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection.
    Kim TY; Myoung HJ; Kim JH; Moon IS; Kim TG; Ahn WS; Sin JI
    Cancer Res; 2002 Dec; 62(24):7234-40. PubMed ID: 12499264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants.
    Dehghan S; Tafaghodi M; Bolourieh T; Mazaheri V; Torabi A; Abnous K; Tavassoti Kheiri M
    Int J Pharm; 2014 Nov; 475(1-2):1-8. PubMed ID: 25148732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response.
    Hemann EA; Sjaastad LE; Langlois RA; Legge KL
    J Virol; 2015 Dec; 90(6):2830-7. PubMed ID: 26719269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice.
    Liu Y; Luo X; Yang C; Yu S; Xu H
    Vaccine; 2011 Aug; 29(34):5778-84. PubMed ID: 21664398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.
    Kim TG; Kim CH; Won EH; Bae SM; Ahn WS; Park JB; Sin JI
    Immunology; 2004 May; 112(1):117-25. PubMed ID: 15096191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
    Davila E; Kennedy R; Celis E
    Cancer Res; 2003 Jun; 63(12):3281-8. PubMed ID: 12810660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
    Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
    Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
    Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
    J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
    Tengvall S; Josefsson A; Holmgren J; Harandi AM
    J Reprod Immunol; 2005 Dec; 68(1-2):53-69. PubMed ID: 16229896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keeping the memory of influenza viruses.
    Combadière B; Sibéril S; Duffy D
    Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
    Jiang JQ; Patrick A; Moss RB; Rosenthal KL
    J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein.
    Li Y; Chen X
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
    Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL
    Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
    Sen G; Chen Q; Snapper CM
    Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.
    Liu J; Wu B; Zhang S; Tan S; Sun Y; Chen Z; Qin Y; Sun M; Shi G; Wu Y; Sun M; Liu N; Ning K; Ma Y; Gao B; Yan J; Zhu F; Wang H; Gao GF
    Eur J Immunol; 2013 Aug; 43(8):2055-69. PubMed ID: 23681926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 ligand preferentially modulates immune response and enhances protection against influenza virus.
    Hashem AM; Gravel C; Chen Z; Yi Y; Tocchi M; Jaentschke B; Fan X; Li C; Rosu-Myles M; Pereboev A; He R; Wang J; Li X
    J Immunol; 2014 Jul; 193(2):722-34. PubMed ID: 24928989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.